Molecular Cloning and Characterization of CAPER, a Novel Coactivator of Activating Protein-1 and Estrogen Receptors
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Transcriptional coactivators either bridge transcription factors and the components of the basal transcription apparatus and/or remodel the chromatin structures. We isolated a novel nuclear protein based on its interaction with the recently described general coactivator activating signal cointegrator-2 (ASC-2). This protein CAPER (for coactivator of activating protein-1 (AP-1) and estrogen receptors (ERs)) selectively bound, among the many transcription factors we tested, the AP-1 component c-Jun and the estradiol-bound ligand binding domains of ERalpha and ERbeta. Interestingly, CAPER exhibited a cryptic autonomous transactivation function that becomes activated only in the presence of estradiol-bound ER. In cotransfections, CAPER stimulated transactivation by ERalpha, ERbeta, and AP-1. Thus, CAPER may represent a more selective transcriptional coactivator molecule that plays a pivotal role for the function of AP-1 and ERs in vivo in conjunction with the general coactivator ASC-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660
Cited by
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Uehara, T., Minoshima, Y., Sagane, K., Sugi, N. H., Mitsuhashi, K. O., Yamamoto, N., Kamiyama, H., Takahashi, K., Kotake, Y., Uesugi, M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2363 · Cited by 396
Coordinate Regulation of Transcription and Splicing by Steroid Receptor Coregulators
Auboeuf, D., Hönig, A., Berget, S. M., & O'Malley, B. W. (2002) · Science · doi:10.1126/science.1073734 · Cited by 357
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
U2AF homology motifs: protein recognition in the RRM world
Kielkopf, C. L., Lücke, S., & Green, M. R. (2004) · Genes & Development · doi:10.1101/gad.1206204 · Cited by 253
Dowhan, D. H., Hong, E. P., Auboeuf, D., Dennis, A. P., Wilson, M. M., Berget, S. M., & O'Malley, B. W. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.025 · Cited by 193
Expanding functional diversity of the coactivators
Lonard, D. M., & O'Malley, B. W. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.001 · Cited by 172
Nijhuis, A., Sikka, A., Yogev, O., Herendi, L., Balcells, C., Ma, Y., Poon, E., Eckold, C., Valbuena, G. N., Xu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28907-3 · Cited by 110
Antonson, P., Schuster, G. U., Wang, L., Rozell, B., Holter, E., Flodby, P., Treuter, E., Holmgren, L., & Gustafsson, J.-Å. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1260-1268.2003 · Cited by 95
“Recently, three different proteins containing RNA-binding domains, termed PIMT, CoAA, and CAPER, were shown to bind to and increase the activity of RAP250 (10, 11 , 43), and a role for RAP250 as a link between CBP/p300 and TRAP/DRIP/ARC coactivator complexes has been proposed (21).”
BackgroundA U1-U2 snRNP interaction network during intron definition
Shao, W., Kim, H.-S., Cao, Y., Xu, Y.-Z., & Query, C. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06234-11 · Cited by 85
“Its human homolog, CAPER, has been proposed to couple transcription with splicing, influencing alternative splicing of the steroid hormone receptor (9, 13).”
BackgroundMahajan, M. A., Das, S., Zhu, H., Tomic-Canic, M., & Samuels, H. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4994-5004.2004 · Cited by 55
CAPER, a novel regulator of human breast cancer progression
Mercier, I., Gonzales, D. M., Quann, K., Pestell, T. G., Molchansky, A., Sotgia, F., Hulit, J., Gandara, R., Wang, C., Pestell, R. G., et al. (2014) · Cell Cycle · doi:10.4161/cc.28156 · Cited by 45
“CAPER was first identified based on its interaction with the activating signal co-integrator-2 (ASC-2), another nuclear receptor co-activator.(19) CAPER is identical to the human protein HCC1.”
BackgroundMethodInfluentialOverexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis
Chai, Y., Liu, X., Dai, L., Li, Y., Liu, M., & Zhang, J.-Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-1819-y · Cited by 42
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression
Sillars-Hardebol, A. H., Carvalho, B., Beliën, J. A. M., de Wit, M., Delis-van Diemen, P. M., Tijssen, M., van de Wiel, M. A., Pontén, F., Meijer, G. A., & Fijneman, R. J. A. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0088-2 · Cited by 38
CAPER as a therapeutic target for triple negative breast cancer
Campbell, M. C., Pontiggia, L., Russell, A. Y., Schwarting, R., Camacho, J., Jasmin, J.-F., & Mercier, I. (2018) · Oncotarget · doi:10.18632/oncotarget.25719 · Cited by 10
Metadata
- Authors
- Jung, D.-J., Na, S.-Y., Na, D. S., & Lee, J. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1229-1234
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2043923025
- Cited by
- 112
- References
- 2
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.